Skip to main content

Analytics

By Jessica Hagen | 02:15 pm | July 23, 2024
The three companies will collaborate with Mayo Clinic nurses to create a genAI documentation workflow tool that will integrate into Epic nursing workflows.
By HIMSS TV | 07:00 am | July 23, 2024
Michael Pace, founder and president of PalmHealthCo, highlights how his company advises organizations, including pharma, in commercialization and go-to-market strategies for digital therapeutics - and his experience at Pear Therapeutics.  
By Adam Ang | 11:21 pm | July 21, 2024
Also, a Hong Kong project has received $5 million in funding to develop LLM-run companion robots for the mentally underserved.
By Jessica Hagen | 03:30 pm | July 19, 2024
The company will use the funds to accelerate its growth, expand the use of its models for different conditions and open an office in Cambridge.
By Adam Ang | 12:34 am | July 19, 2024
The Australian government-approved therapy has shown "remarkable" results after 18 sessions.
By Jessica Hagen | 10:30 am | July 18, 2024
The AKF and Ubie will fine-tune the digital health company's AI-enabled symptom checker to help accelerate kidney disease diagnosis.
By HIMSS TV | 07:00 am | July 18, 2024
Ashok Chennuru, global chief data and insights officer at Elevance Health, and Oron Afek, CEO of Vim, discuss scaling artificial intelligence to accelerate workflows, enhance patient care and unlock personalized medicine.  
HIMSS24
By HIMSS TV | 05:25 pm | July 17, 2024
Joe O'Brien, head of sales, digital health at LG Electronics, says the company plans to use AI tools in smart hospital rooms to provide better patient experiences by supplementing, not replacing, in-person care.  
By HIMSS TV | 07:00 am | July 17, 2024
Adjunct faculty at Stanford Health Care and CMO and cofounder of Atropos Health, Saurabh Gombar, discusses a study analyzing five LLMs and their accuracy in producing actionable and reliable evidence for healthcare-related questions.  
By Jessica Hagen | 05:50 pm | July 16, 2024
Thyme Care secures $60 million in Series B funding, and Neuspera Medical garners $23 million.